Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorSEVIN, Thibaud
dc.contributor.authorDANIAU, Come
dc.contributor.authorALFANDARI, Serge
dc.contributor.authorPIEDNOIR, Emmanuel
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorDUMARTIN, Catherine
dc.contributor.authorBLANCHARD, Herve
dc.contributor.authorSIMON, Loic
dc.contributor.authorBERGER-CARBONNE, Anne
dc.contributor.authorLE VU, Stephane
dc.date.accessioned2021-07-08T11:54:05Z
dc.date.available2021-07-08T11:54:05Z
dc.date.issued2021-05-27
dc.identifier.issn0195-6701en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/106466
dc.description.abstractEnBACKGROUND: Monitoring the use of antimicrobials in hospitalized patients is critical owing to the risk of resistance selection. This study aims to describe the patterns of antimicrobial prescription for the most frequent healthcare-associated infections (HAI) in France, relating drugs and microbiological data. METHODS: We used data from the 2017 point-prevalence survey of HAI and antimicrobial use in France, a large nationally representative sample survey of inpatients. We sought unambiguous correspondence between individual indications of antibiotic regimen and HAI sites to determine which molecules were directed towards which pathogen, considering its resistance profile. RESULTS: Among 75698 adult patients from 401 hospitals, 5.1% had an active HAI and 4.3% were being treated for an HAI. The two most frequent antibiotic indications were lower respiratory tract (LRTI, 27.7%) and urinary tract infections (UTI, 18.4%). For LRTI, the most prescribed antibiotic was amoxicillin-clavulanic acid (27.6%) and most frequently isolated pathogens (each accounting for around 17% of isolates) were Staphylococcus aureus, Pseudomonas aeruginosa and Escherichia coli. Meticillin-resistant S. aureus LRTI was more likely to be treated with linezolid. For UTI, ofloxacin, ceftriaxone, amoxicillin/co-amoxiclav were most-prescribed (∼13% each) and E. coli predominantly isolated (52.0%). Extended-spectrum beta-lactamase-producing E. coli UTI were more likely treated by fosfomycin, pivmecillinam or ertapenem. CONCLUSIONS: This study provides a baseline of antimicrobial use in relation to microbiological information in patients with the most common HAI. These results can serve to direct future effort of antimicrobial stewardship. Our work could be extended to a broader population, notably in Europe where similar surveys have been conducted.
dc.language.isoENen_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.subject.enAntibiotic
dc.subject.enPrevalence study
dc.subject.enHealthcare-associated infections
dc.subject.enHospital
dc.subject.enInfection
dc.title.enPatterns of antibiotic use in hospital-acquired infections
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.jhin.2021.05.008en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed34052283en_US
bordeaux.journalJournal of Hospital Infectionen_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamPharmacoEpi-Drugsen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03281675
hal.version1
hal.date.transferred2021-07-08T11:54:09Z
hal.exporttrue
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Journal%20of%20Hospital%20Infection&rft.date=2021-05-27&rft.eissn=0195-6701&rft.issn=0195-6701&rft.au=SEVIN,%20Thibaud&DANIAU,%20Come&ALFANDARI,%20Serge&PIEDNOIR,%20Emmanuel&DUMARTIN,%20Catherine&rft.genre=article


Fichier(s) constituant ce document

Thumbnail
Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée